Dark
Light
Today: July 21, 2024
May 3, 2024
1 min read

Injecting Capital: Mortgage Automator partners with BVP Forge for growth

TLDR:

  • Mortgage Automator partners with BVP Forge for a recapitalization deal to accelerate growth
  • Mortgage Automator to expand services and reach in private and asset-based lending industry

SaaS company Mortgage Automator has secured a capital injection from private equity firm BVP Forge in a major recapitalization deal aimed at driving its next phase of growth. The partnership is expected to enhance Mortgage Automator’s services and expand its reach across the private and asset-based lending industry.

CEO Pavel Tchourliaev and Chief Strategy Officer Joseph Fooks expressed excitement about leveraging Forge’s resources to further enhance their range of products and services. Tom Obermaier, operating partner at BVP Forge, confirmed that Mortgage Automator will now have access to Forge’s operating resource program and growth IP, workshops, and programming.

With over 375 customers in countries like the United States, Canada, Australia, and New Zealand, Mortgage Automator manages more than $20 billion in transactions through its platform. The platform, designed by industry veterans, offers a user-friendly interface that simplifies complex processes like CRM, origination, execution, servicing, and reporting.

BVP Forge, the private equity and venture capital firm that facilitated the recapitalization, focuses on investing in software-enabled businesses poised for growth. Partner Rob Arditi praised Mortgage Automator for its high degree of customer satisfaction, remarkable growth rates, and sustained profitability.

This collaboration between Mortgage Automator and BVP Forge is expected to bring significant benefits to the company’s customers and extend its market-leading SaaS platform across the full private lending value chain and ecosystem.

Previous Story

Increasing Private Investment Fuels Growth in Nigerian Climate-Tech Startups

Next Story

Former DFS Regulator Raises $51M for Crypto Fund with Winklevoss

Latest from Blog

Antheia Secures $17M Investment

TLDR: Antheia, a pharmaceutical ingredient manufacturer based in Menlo Park, CA, raised $17M in funding. The funding included a non-dilutive two-year project agreement up to $11M through the BioMaP Consortium. Antheia, led
Go toTop